Guldane Cengiz Seval, Sosana Delimpasi, Vladimir I. Vorobyev, Hang Quach, Ivan Špička, Jakub Radocha, Youngil Koh, Tadeusz Robak, Felipe de Arriba de la Fuente, Esther González García, Peli̇n Aytan, Silvia Mangiacavalli, Elena Zamagni, Margaret Polinkovsky, Marie Duggan, Joanna Grams, Elisabet Manasanch, María-Victoria Mateos, Suzanne Trudel, Meletios A. Dimopoulos. "PFS2 outcomes by prior therapy from DREAMM-8: A phase 3 study assessing belantamab mafodotin (belamaf), pomalidomide, and dexamethasone (BPd) vs pomalidomide, bortezomib, and dexamethasone (PVd) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.7566